Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
Alain Depierre, Claude Chastang, Élisabeth Quoix et al. · Annals of Oncology · 1994
Cited by 219 works. doi:10.1093/oxfordjournals.annonc.a058687
Authors
- Alain Depierre
- Claude Chastang
- Élisabeth Quoix
- B Lebeau
- Nadine Paillot
- É. Lemarié
- Bernard J. Milleron
- Denis Moro‐Sibilot
- Jean Baptiste Clavier
References
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
- Regression Models and Life-Tables
- Regression Models and Life-Tables
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
- Planning the size and duration of a clinical trial studying the time to some critical event
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules
- Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
- Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.